Delivery Order SPE2DR25D3012-SPE2DR26F4D0Z
- Not listed
- The Defense Logistics Agency awarded a $11.2K delivery order to AmerisourceBergen Drug Corp for Tagrisso 80 mg tablets (30-count units) on December 2, 2025, with completion scheduled for December 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, supplies a...
- The Defense Logistics Agency awarded a delivery order valued at $31,987.71 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units) on August 27, 2025, with an ultimate completion date of September 18, 2025. This competitive award, with no set-aside designation, reflects firm fixed-price pricing terms and represents a pharmaceutical supply delivery to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Tagrisso 40 mg tablets (30-count packaging) under a firm fixed-price contract valued at $11,214.04. The delivery order, which is expected to conclude by January 6, 2026, represents a non-set-aside competitive award issued to the prime contractor's corporate office located in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's broader...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Tagrisso 80 mg tablets in a quantity of 30 units, with a contract ceiling value of $106,625.70. This is a firm fixed-price delivery order with an ultimate completion date of October 17, 2025, and represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Tagrisso 80 mg tablets (30-count units) with a contract value of $21,325.14. This non-set-aside delivery order utilizes firm fixed pricing and is scheduled for completion by September 30, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and has established...
- The Defense Logistics Agency awarded a $10,662.57 delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Tagrisso 80 mg tablets (30-count packages). This firm fixed-price contract, with an ultimate completion date of July 10, 2025, represents a competitively awarded, non-set-aside procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Tagrisso 80 mg tablets (30-count units) valued at $10,662.57. This firm fixed price delivery order, with an ultimate completion date of September 9, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively procured with no set-aside designation. AmerisourceBergen,...
- The Defense Logistics Agency awarded a $11,236.71 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Tagrisso 80 mg tablets (30-count). The contract will be performed at the contractor's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of December 1, 2025. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's broader pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Tagrisso 80 mg tablets in a quantity of 30 units. This firm fixed-price delivery order, awarded on September 23, 2025, carries a ceiling value of $10,662.57 and is scheduled for completion by October 15, 2025. The award was made on a competitive basis without any set-aside designation, and the place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 28, 2025, for the supply of Tagrisso 80 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at approximately $127K, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 20, 2025. The award was made through open competition with no set-aside designation, reflecting...
- SPE2DR25D3012Indefinite Delivery Contract
- SPE2DR25D3012-SPE2DR26F4D0ZDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Tagrisso 80 mg tablets (30-count units) with a contract ceiling value of $22,473.42. This is a firm fixed-price delivery order with an ultimate completion date of December 31, 2025, and represents a non-competitive set-aside award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement valued through December 2026 that provides comprehensive global pharmaceutical support to military healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves as a prime contractor for the Defense Logistics Agency's Medical Supply Chain. The company supplies a broad portfolio of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains. As a for-profit organization registered in the System for Award Management, AmerisourceBergen has demonstrated sustained capability to fulfill federal medical supply requirements through open competition and serves multiple federal healthcare systems including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.5k | 12/8/25 |